These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 13378057)

  • 1. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report.
    MILLER M; CRAIG JW
    Metabolism; 1956 Mar; 5(2):162-4. PubMed ID: 13296878
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
    COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
    J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical studies on the hypoglycaemic action of the sulphonylureas.
    BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
    Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral hypoglycemic agents for treatment of diabetes mellitus.
    HACKEDORN HM
    Northwest Med; 1956 Sep; 55(9):965-7. PubMed ID: 13358973
    [No Abstract]   [Full Text] [Related]  

  • 6. The mechanism of action of the sulfonylureas in diabetes mellitus.
    LEVINE R; SOBEL GW
    Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Practical indications for treatment of diabetes mellitus by hypoglycemic sulfamides administered orally].
    RAVINA A; PESTEL
    Bull Mem Soc Med Hop Paris; 1956; 72(16-18):535-8. PubMed ID: 13342957
    [No Abstract]   [Full Text] [Related]  

  • 8. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference.
    KRAHL ME; LUKENS FD; RICKETTS HT
    Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436
    [No Abstract]   [Full Text] [Related]  

  • 9. D 860, a new antidiabetic remedy.
    HEIKINHEIMO R
    Duodecim; 1957; 73(1):53-5. PubMed ID: 13427681
    [No Abstract]   [Full Text] [Related]  

  • 10. Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison.
    WRENSHALL GA; BEST CH
    Can Med Assoc J; 1956 Jun; 74(12):968-72. PubMed ID: 13329944
    [No Abstract]   [Full Text] [Related]  

  • 11. The hypoglucemic sulfonylurea drugs; an interim evaluation.
    STETTEN D
    Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical applications of hypoglycemic and antidiabetic drugs].
    LANDABURE PB
    Dia Med; 1956 Jun; 28(40):1100-6. PubMed ID: 13344290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoglycemic effect of various sulfamides administered orally; treatment of diabetes mellitus with BZ 55].
    SCALABRINO R; PASQUARIELLO G
    Minerva Med; 1956 Jan; 47(9):270-3. PubMed ID: 13309001
    [No Abstract]   [Full Text] [Related]  

  • 14. Methods of selection of diabetic patients sensitive to sulfonylurea compounds.
    DUNCAN GG; JOINER CL; LEE CT
    Metabolism; 1956 Nov; 5(6 Part 2):964-71. PubMed ID: 13378066
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
    DAVIDSON JW; UNGER RH
    J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of the mechanism of action of sulfonylurea derivatives.
    GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
    Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
    [No Abstract]   [Full Text] [Related]  

  • 17. The oral antidiabetic compounds; selection of patients by means of a blood sugar response test.
    WELLER C
    N Y State J Med; 1956 Nov; 56(21):3333-7. PubMed ID: 13369787
    [No Abstract]   [Full Text] [Related]  

  • 18. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan].
    FRAENKEL KA; SCHULZ K
    Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175
    [No Abstract]   [Full Text] [Related]  

  • 19. CURRENT investigation of the hypoglycemic action of sulfonylureas.
    Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations with sulfonylureas in diabetes.
    BROWN FR; FRISKEY RW; KINSELL LW; MICHAELS GD
    Metabolism; 1956 Nov; 5(6 Part 2):864-7. PubMed ID: 13378055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.